Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Lynette M. Sholl
ResearcherPublications, citations & collaboration network
Lynette M. Sholl is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 1,108 works, 40,306 citations, an h-index of 98 and an i10-index of 323.
1,108
Works
40,306
Citations
98
h-index
323
i10-index
How has Lynette M. Sholl's publication output changed over time?
ScholarIQpublication output · 2013–2021
Output grew200% over the shown period — from 1 works in 2013 to 3 in 2021.
1
1
1
5
1
3
201320152016201820202021
What are the most-cited papers on Lynette M. Sholl?
ScholarIQmost cited works
<i>STK11/LKB1</i> Mutations and PD-1 Inhibitor Resistance in <i>KRAS</i>-Mutant Lung Adenocarcinoma
Ferdinandos Skoulidis, Michael E. Goldberg, Danielle Greenawalt, Matthew D. Hellmann, Mark M. Awad, Justin F. Gainor, Alexa B. Schrock, Ryan J. Hartmaier, Sally E. Trabucco, Laurie M. Gay, Siraj M. Ali, Julia A. Elvin, Gaurav Singal, Jeffrey S. Ross, David Fabrizio, Péter M. Szabó, Chang Han, Ariella Sasson, Sujaya Srinivasan, Stefan Kirov, Joseph D. Szustakowski, Patrik Vitazka, Robin Edwards, José A. Bufill, Neelesh Sharma, Sai‐Hong Ignatius Ou, Nir Peled, David R. Spigel, Hira Rizvi, Elizabeth Jiménez Aguilar, Brett W. Carter, Jeremy Erasmus, Darragh Halpenny, Andrew J. Plodkowski, Niamh M. Long, Mizuki Nishino, Warren L. Denning, Ana Galán‐Cobo, Haïfa Hamdi, Taghreed Hirz, Pan Tong, Jing Wang, Jaime Rodriguez‐Canales, Pamela Villalobos, Edwin R. Parra, Neda Kalhor, Lynette M. Sholl, Jennifer L. Sauter, Achim A. Jungbluth, Mari Mino–Kenudson, Roxana Azimi, Yasir Y. Elamin, Jianjun Zhang, Giulia C. Leonardi, Fei Jiang, Kwok‐Kin Wong, J. Jack Lee, Vassiliki A. Papadimitrakopoulou, Ignacio I. Wistuba, Vincent A. Miller, Garrett M. Frampton, Jedd D. Wolchok, Alice T. Shaw, Pasi A. Jänne, Philip J. Stephens, Charles M. Rudin, William J. Geese, Lee A. Albacker, John V. Heymach
Cancer Discovery. 20181,635 CitationsOPEN ACCESS
PD-L1 as a biomarker of response to immune-checkpoint inhibitors
Deborah B. Doroshow, Sheena Bhalla, Mary Beth Beasley, Lynette M. Sholl, Keith M. Kerr, Sacha Gnjatic, Ignacio I. Wistuba, David L. Rimm, Ming‐Sound Tsao, Fred R. Hirsch
S41981144. 20211,593 Citations
The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015
Andrew G. Nicholson, Ming‐Sound Tsao, Mary Beth Beasley, Alain Borczuk, Élisabeth Brambilla, Wendy A. Cooper, Sanja Đačić, Deepali Jain, Keith M. Kerr, Sylvie Lantuéjoul, Masayuki Noguchi, Mauro Papotti, Natasha Rekhtman, Giorgio V. Scagliotti, Paul Van Schil, Lynette M. Sholl, Yasushi Yatabe, Akihiko Yoshida, William D. Travis
Journal of Thoracic Oncology. 20211,534 CitationsOPEN ACCESS
Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors
Esra A. Akbay, Shohei Koyama, Julián Carretero, Abigail Altabef, Jeremy H. Tchaicha, Camilla L. Christensen, Oliver R. Mikse, Andrew D. Cherniack, Ellen M. Beauchamp, Trevor J. Pugh, Matthew D. Wilkerson, Peter E. Fecci, Mohit Butaney, Jacob B. Reibel, Margaret Soucheray, Travis J. Cohoon, Pasi A. Jänne, Matthew Meyerson, D. Neil Hayes, Geoffrey I. Shapiro, Takeshi Shimamura, Lynette M. Sholl, Scott J. Rodig, Gordon J. Freeman, Peter S. Hammerman, Glenn Dranoff, Kwok‐Kin Wong
Cancer Discovery. 20131,247 CitationsOPEN ACCESS
Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology
Neal I. Lindeman, Philip T. Cagle, Dara L. Aisner, Maria E. Arcila, Mary Beth Beasley, Eric Bernicker, Carol Colasacco, Sanja Đačić, Fred R. Hirsch, Keith M. Kerr, David J. Kwiatkowski, Marc Ladanyi, Jan A. Nowak, Lynette M. Sholl, Robyn Temple‐Smolkin, Benjamin Solomon, Lesley Souter, Erik Thunnissen, Ming‐Sound Tsao, Christina B. Ventura, Murry W. Wynes, Yasushi Yatabe
S139062638. 2018944 CitationsOPEN ACCESS
Related on ScholarIQ
Brigham and Women's Hospital
Institution
<i>STK11/LKB1</i> Mutations and PD-1 Inhibitor Resistance in <i>KRAS</i>-Mutant Lung Adenocarcinoma
Paper
PD-L1 as a biomarker of response to immune-checkpoint inhibitors
Paper
The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015
Paper
Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors
Paper
Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology
Paper